Kevin A. Bybee, MD

Kevin A. Bybee, MD, is a board-certified and fellowship-trained cardiologist with Saint Luke's Cardiovascular Consultants. He was born and raised in Quincy, IL and graduated from Southern Illinois University School of Medicine. He then completed his residency training in Internal Medicine at the Mayo Clinic where he was awarded the Outstanding Achievement award.

Dr. Bybee completed his Cardiovascular fellowship training at the Mayo Clinic with additional training in advanced non-invasive cardiac imaging. During his fellowship training, he attained the rank of Assistant Professor of Medicine at the Mayo Medical School.

He is Board Certified in Cardiovascular Disease and joined the cardiology department at Saint Luke's Health System in 2005. He primarily sees patients at Saint Luke's South in Overland Park, KS where he serves as the Medical Director for cardiovascular services.

Dr. Bybee is an Associate Professor of Medicine at the University of Missouri-Kansas City School of Medicine and is actively involved in cardiovascular research. He has published more than 40 peer-reviewed manuscripts.

1. O’Keefe JH, Bybee KA, Lavie CJ, Hammill SC. ST-Segment Elevation: Defined by the Company it Keeps. Mayo Clin Proc 2012;87:610-613.
 
2. Bhatti SK, Bybee KA, Khalid A, Magalski, Main ML. Transient apical ballooning and apical sparing variant stress cardiomyopathy in the same patient. Eur Heart J Cardiovasc Imaging 2012;13:201.
 
3. Safley DM, Koshy S, Grantham JA, Bybee KA, House JA, Kennedy KF, Rutherford BD. Changes in myocardial ischemic burden following percutaneous coronary intervention of chronic total occlusions. Catheter Cardiovasc Inter. 2011;78:337-343.
 
4. Bybee KA, Dew ML, Lawhorn SL, Steven TL.  Cardiovascular Disease in Women
       Essentials.  Jones & Bartlett Learning, LLC. 2010.
 
5. Bybee KA, Lee JH, Markiewicz R, Longmore R, McGhie AI; O’Keefe JH, Hsu B-L, Kennedy K, Thompson RC, Bateman TM. Diagnostic and clinical benefit of combined coronary calcium and perfusion assessment in patients undergoing PET/CT myocardial perfusion stress imaging. J Nucl Cardiol 2010;17:188-196.
 
6. Abuissa H, O’Keefe JH, Bybee KA.  Statins as antiarrhythmic agents: A systematic review of effects on atrial fibrillation. Clin Cardiol 2009;32:544-548.
 
7. Abuissa H, O’Keefe JH, Bybee KA.  Statins as antiarrhythmic agents: A systematic review of effects on ventricular arrhythmias. Clin Cardiol 2009;32:549-52.
 
8. Lee JH, Jones PG, Bybee KA, O’Keefe JH. A longer course of Varenicline therapy improves smoking cessation rates. Preventive Cardiology 2008;11:210-214.
 
9. Bybee KA, Prasad A.  Stress-Induced Cardiomyopathy Syndromes. Circulation 2008;118:397-409.
 
10. Kara T, Novak M, Nykodym J, Bybee KA, Meluzin J, Orban M, Novakova Z, Lipoldova J, Hayes DL, Soucek M, Vitovec J, Somers VK.  Acute Effects of Cardiac Resynchronization Therapy on Sleep Disordered Breathing in Patients with Chronic Heart Failure. Chest 2008;134:87-93.
 
11. Bybee KA, Lee J, O’Keefe JH. Cumulative clinical trial data on atorvastatin for the reduction in cardiovascular events.  Current Medical Research and Opinion 2008;24(4):1217-29.
 
12. Bybee KA, Bateman TM. Symptom-limited exercise during vasodilator stress: Best of both worlds?  Journal of Nuclear Cardiology 2008;15(1):3-6.
 
13. O’Keefe JH, Bybee KA, Lavie CJ.  Intensive lipid intervention in the post-ENHANCE era. Mayo Clin Proc 2008;83:867-869.
 
14. O’Keefe JH, Bybee KA, Lavie C. Alcohol and cardiovascular disease: The razor-sharp double-edged sword.  Journal of the American College of Cardiology 2007;50:1009-1014.
 
15. Powell BD, Bybee KA, Valeti U, Rosales AG, Thomas RJ; Kopecky SL, Mullany CJ, Wright RS.  Influence of preoperative lipid lowering therapy on postoperative outcomes in patients undergoing coronary artery bypass graft surgery. American Journal of Cardiology 2007; 99:785-789.
 
16. Bybee KA, Motiei A, Syed I, Kara T, Lennon R, Murphy J, Wright RS, Rihal C. Electrocardiographic differentiation between transient left ventricular apical ballooning syndrome and anterior ST-segment elevation myocardial infarction. Journal of Electrocardiology 2007;40(1):38.e1-6.
 
17. Elesber A, Lerman A, Bybee KA, Murphy JG, Barsness G, Singh M, Rihal CS, Prasad A. Myocardial perfusion in apical ballooning syndrome: correlates of myocardial injury. American Heart Journal 2006;152:469.e9-13.
 
18. Powell B, Bybee KA, Lennon R, Freeman B, Redfield MM, Rihal C. Association between obesity and left ventricular remodeling and left ventricular function in patients without coronary artery disease. American Journal of Cardiology 2006;98:116-120.
 
19. Bybee KA, Murphy J, Wright RS, Prasad A, Rihal CS, Chareonthaitawee P. Acute impairment of regional myocardial glucose utilization in the apical ballooning (Takotsubo) syndrome. Journal of Nuclear Cardiology 2006;13(2):244-250.
 
20. Veselka J, Procházková S, Duchoňová R, Homolová I, Fedorová L, Tesař D, Bybee KA. Pre-procedural statin therapy reduces the risk and extent of cardiac biomarker release following percutaneous coronary intervention. Heart and Vessels 2006;21(3):146-151.
 
21. Bybee KA, Das S, O’Keefe JH. The rational and indications for angiotensin II receptor blockers in heart failure. Heart Failure Clinics of North America 2006;2:81-88.
 
22. Wright RS, Bybee KA, Miller W, Laudon DA, Rosales AG, Kopecky SL, Murphy JG, Jaffe A. Reduced risks of death and heart failure are associated with statin administration within the first 24 hours of acute myocardial infarction. International Journal of Cardiology 2006;108(3):314-319. 
 
23. Elesber A, Bybee KA, Prasad A, Wright RS, Lerman A, Rihal CS. Right ventricular dysfunction in the transient apical ballooning syndrome: Incidence and impact on clinical outcomes. Journal of the American College of Cardiology 2006;47:1082-1083.
 
24. Bybee KA, Kara T. Transient left ventricular apical ballooning syndrome. Clinical Cardiology 2005;28:584.
 
25. Bybee KA, Powell BD, Kopecky SL, Rosales G, Mullany C, Wright RS.  Preoperative aspirin therapy is associated with improved postoperative outcomes in patients undergoing coronary artery bypass surgery. Circulation 2005; 112: suppl I: 286-292.
 
26. Mahapatra S, Bybee KA, Bunch TJ, Espinosa RE, Sinak LJ, McGoon MD, Hayes DL. Incidence and predictors of cardiac perforation after permanent pacemaker placement. Heart Rhythm 2005;2:907-911.
 
27. Bybee KA, Kara T, Prasad A, Lerman A, Barsness G, Wright RS, Rihal C.  Transient left ventricular apical ballooning: a syndrome that mimics ST-segment elevation myocardial infarction. Annals of Internal Medicine 2004;141:858-865.
 
28. Hoffmann M, Bybee K, Accurso V, Somers VK. Sleep apnea and hypertension.  Minerva Medica 2004; 95:281-290.
 
29. Bybee KA, Kopecky SL, Williams B, Murphy J, Wright RS.  Reduced creatine kinase release with statin use at the time of myocardial infarction. International Journal of Cardiology 2004;96:461-466.
 
30. Svatikova A, Wolk R, Wang HH, Otto M, Bybee KA, Singh RJ, Somers VK. Circulating free nitrotyrosine in obstructive sleep apnea. American Journal of Physiology Regul Integr Comp Physiol 2004; 287:R284-R287.
 
31. Bybee KA, Prasad A, Barsness G, Lerman A, Murphy J, Jaffe A, Wright RS, Rihal C.  Clinical characteristics and TIMI frame counts in women with transient left ventricular apical ballooning syndrome. American Journal of Cardiology 2004;94:343-346.
 
32. Bybee KA, Powell B, Williams B, Kopecky S, Wright RS.  Superior early cholesterol control and achievement of ATP III LDL goals with statin therapy at the time of hospital discharge following acute myocardial infarction. American Journal of Cardiology 2004;93:776-779.
 
33. Bybee KA, Wright RS, Kopecky SL. Effect of early statin therapy after acute coronary syndromes: A concise review of the recent data. Cardiology in Review 2002; 10(5):301-305.
 
34. Wright RS, Murphy JG, Bybee KA, Kopecky SL, LaBlanche JM. Statin lipid lowering therapy in patients with acute myocardial infarction and unstable angina: A practical review of efficacy and mechanism of benefit. Mayo Clinic Proceedings 2002;77(10): 1085-1092.
 
35. Bybee KA, Wright RS, Williams B, Murphy J, Holmes D, Kopecky S.  Effect of concomitant or very early statin administration on in-hospital mortality and re-infarction rates in patients with acute myocardial infarction. American Journal of Cardiology 2001;87:771-774.
 
36. Orford JL, Fasseas P, Denktas AE, Bybee KA, Rihal CS, Holmes DR.  Refractory angina and anterior ischemia in a patient with a patent left internal mammary artery bypass graft. Journal of Invasive Cardiology 2001;13:763-766.
 
 
37. Bybee KA, O’Keefe JH, Harris WS, Garg S, George SJ, Bateman TM.  Lipid risk factor correlates of ischemic heart disease as diagnosed by myocardial perfusion scintigraphy. Preventive Cardiology 2000;3:154-159.